Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/29/18 → 7/31/19 |
Funding
- Inc Research Inc: $2,256.00
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study of Gantenerumab in Patients With Prodromal to Mild Alzheimer's Disease
- Jicha, Gregory (PI)